Western medicine composition for treating primary prosopalgia and application thereof

A trigeminal neuralgia, primary technology, applied in the field of western medicine, can solve the problems of hearing loss, incurable, air embolism and trochlear, and achieve the effects of reduced incidence rate, good treatment effect and high safety.

CN107007592AInactive Publication Date: 2017-08-04WEST ANHUI UNIV
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2017-08-04
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention discloses a Western medicine composition for treating primary prosopalgia and an application thereof. The active component of the Western medicine composition comprises, by weight, 8-14 parts of catechinic acid, 4-9 parts of nicotinamide and 11-17 parts of oleanolic acid; the adult drug dosage of the active component is 28-31 mg / kg / day. Compared with the existed carbamazepine drug for treating primary prosopalgia, the Western medicine composition is high in safety and good in treatment effect. The clinical experiment proves that the morbidity ratio of the prosopalgia of patients is greatly reduced after the patients take the Western medicine composition; the effect in relieving pain before and after treatment is greater as compared with that of the regular drug; the drug can safely cure the patients with primary prosopalgia in a short term; the total efficiency is up to 98%.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of western medicine, in particular to a western medicine composition for treating primary trigeminal neuralgia and its application. Background technique

[0002] Trigeminal neuralgia is the most common cranial nerve disease. It is mainly manifested by recurrent paroxysmal severe pain in the distribution area of ​​the trigeminal nerve on one side of the face. The incidence rate in domestic statistics is 52.2 / 100,000. Females are slightly more than males. May increase with age. Trigeminal neuralgia mostly occurs in middle-aged and elderly people, and the right side is more common than the left side. The characteristics of the disease are: in the trigeminal nerve distribution area of ​​the head and face, the onset is sudden, sudden arrest, lightning-like, knife-like, burning-like, intractable, unbearable severe pain. Talking, washing your face, brushing your teeth, or even walking with a gentle breeze can cau...

Examples

Embodiment 1

[0021] In the embodiment of the present invention, a western medicine composition for treating primary trigeminal neuralgia, the active ingredient is composed of the following components in parts by weight: 8 parts of catechin, 9 parts of nicotinamide and 11 parts of oleanolic acid share.

Embodiment 2

[0023] In the embodiment of the present invention, a western medicine composition for treating primary trigeminal neuralgia, the active ingredient is composed of the following components in parts by weight: 14 parts of catechin, 4 parts of nicotinamide and 17 parts of oleanolic acid share.

Embodiment 3

[0025] In the embodiment of the present invention, a western medicine composition for treating primary trigeminal neuralgia, the active ingredient is composed of the following components in parts by weight: 10 parts of catechin, 7 parts of nicotinamide and 13 parts of oleanolic acid share.